Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 4Colorectal Neoplasms 4Rectal Neoplasms 2Pancreatic Neoplasms 2Pancreatic Fistula 1Intestinal Neoplasms 1Exanthema 1Duodenal Neoplasms 1Diarrhea 1Colonic Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Anti-Bacterial Agents × Gastrointestinal × Clear all
NCT04003181 2021-09-08

The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon

University of Aarhus

Phase NA Completed
64 enrolled
Gastrointestinal

Colonic Neoplasms, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡